Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
5,452.86
4,648.10
4,208.71
3,742.64
3,340.99
2,889.69
2,587.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,452.86
4,648.10
4,208.71
3,742.64
3,340.99
2,889.69
2,587.87
Raw Material Cost
916.51
846.60
939.43
878.36
779.34
706.41
560.33
Purchase of Finished goods
229.79
249.80
166.35
146.28
136.10
89.54
112.13
(Increase) / Decrease In Stocks
37.46
-25.64
-39.21
25.76
-83.17
-150.90
-16.75
Employee Cost
1,291.15
1,089.69
900.34
785.14
645.78
548.25
485.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-2,474.91
1,228.15
1,069.86
1,123.85
933.64
697.83
763.24
Total Expenditure (Excl Depreciation)
0.00
3,388.60
3,036.77
2,959.39
2,411.69
1,891.13
1,904.54
Operating Profit (PBDIT) excl Other Income
5,452.86
1,259.50
1,171.94
783.25
929.30
998.56
683.33
Other Income
0.00
94.50
84.60
98.64
115.68
25.98
92.19
Operating Profit (PBDIT)
0.00
1,354.00
1,256.54
881.89
1,044.98
1,024.54
775.52
Interest
16.11
20.73
7.21
5.84
10.20
8.27
11.91
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-3.92
Gross Profit (PBDT)
0.00
1,333.27
1,249.33
876.05
1,034.78
1,016.27
759.69
Depreciation
173.14
144.11
135.40
130.80
125.30
116.09
95.72
Profit Before Tax
0.00
1,189.16
1,113.93
745.25
909.48
900.18
663.97
Tax
0.00
268.77
297.76
157.27
196.80
246.31
196.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,056.00
920.39
816.17
587.98
712.68
653.87
467.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,056.00
920.39
816.17
587.98
712.68
653.87
467.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,056.00
920.39
816.17
587.98
712.68
653.87
467.70
Equity Capital
25.07
25.27
25.27
25.27
17.17
17.39
17.54
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
4,502.02
3,765.22
3,542.09
3,362.72
3,247.18
2,978.24
2,581.33
Earnings per share (EPS)
84.24
72.84
64.6
46.54
55.34
75.2
53.33
Diluted Earnings per share
84.51
73.33
64.77
45.89
54.96
75.09
53.6
Operating Profit Margin (Excl OI)
0.0%
27.1%
27.85%
20.93%
27.82%
34.56%
26.41%
Gross Profit Margin
0.0%
28.68%
29.68%
23.41%
30.97%
35.17%
29.36%
PAT Margin
19.37%
19.8%
19.39%
15.71%
21.33%
22.63%
18.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.31% vs 10.44% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 14.73% vs 12.77% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -100.00% vs 7.47% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -22.29% vs 187.52% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Ajanta Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
5,452.86
8,939.59
-3,486.73
-39.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,452.86
8,939.59
-3,486.73
-39.00%
Raw Material Cost
916.51
2,276.82
-1,360.31
-59.75%
Purchase of Finished goods
229.79
547.78
-317.99
-58.05%
(Increase) / Decrease In Stocks
37.46
-46.05
83.51
181.35%
Employee Cost
1,291.15
1,983.99
-692.84
-34.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
-2,474.91
2,450.91
-4,925.82
-200.98%
Total Expenditure (Excl Depreciation)
0.00
7,213.45
-7,213.45
-100.00%
Operating Profit (PBDIT) excl Other Income
5,452.86
1,726.14
3,726.72
215.90%
Other Income
0.00
92.80
-92.80
-100.00%
Operating Profit (PBDIT)
0.00
1,818.94
-1,818.94
-100.00%
Interest
16.11
84.93
-68.82
-81.03%
Exceptional Items
0.00
-205.05
205.05
100.00%
Gross Profit (PBDT)
0.00
1,528.96
-1,528.96
-100.00%
Depreciation
173.14
397.82
-224.68
-56.48%
Profit Before Tax
0.00
1,131.14
-1,131.14
-100.00%
Tax
0.00
343.61
-343.61
-100.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,056.00
787.53
268.47
34.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,056.00
787.53
268.47
34.09%
Share in Profit of Associates
0.00
-2.29
2.29
100.00%
Minority Interest
0.00
-47.56
47.56
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,056.00
737.68
318.32
43.15%
Equity Capital
25.07
25.37
-0.30
-1.18%
Face Value
2.00
1.00
0.00
Reserves
4,502.02
6,923.08
-2,421.06
-34.97%
Earnings per share (EPS)
84.24
29.08
55.16
189.68%
Diluted Earnings per share
84.51
29.08
55.43
190.61%
Operating Profit Margin (Excl OI)
0.00%
19.31%
0.00
-19.31%
Gross Profit Margin
0.00%
17.10%
0.00
-17.10%
PAT Margin
19.37%
8.81%
0.00
10.56%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 5,452.86 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.31% vs 10.44% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 1,056.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.73% vs 12.77% in Mar 2025
Annual - Operating Profit (PBDIT)
No Operating Profit (PBDIT) in the last few periods
Annual - Interest
Interest 16.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -22.29% vs 187.52% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods






